Gabapentin for Postoperative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical...

Area of Science:

• Urology
• Anesthesiology
• Pharmacology

Background:

• Postoperative pain management after scrotal surgery is crucial for patient recovery and satisfaction.
• Gabapentin is an anticonvulsant medication with analgesic properties that may be beneficial in managing postoperative pain.

Purpose of the Study:

• To evaluate the efficacy and safety of gabapentin in alleviating postoperative pain in patients undergoing scrotal surgery for male infertility.
• To compare pain scores, opioid consumption, patient satisfaction, and adverse events between gabapentin and placebo groups.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted involving 70 male patients undergoing scrotal surgery.
• Patients received either gabapentin (600 mg preoperatively, 300 mg TID for 3 days postoperatively) or a placebo.
• Pain scores, opioid usage, patient satisfaction, and adverse events were the primary and secondary outcome measures.

Main Results:

• Gabapentin significantly reduced both initial and final postoperative mean pain scores compared to placebo (P = .035 and P = .0097, respectively).
• No statistically significant differences were observed in opioid usage or patient satisfaction between the groups.
• Adverse events were not significantly different between the gabapentin and placebo groups.

Conclusions:

• Perioperative gabapentin administration leads to a statistically and clinically significant reduction in pain following scrotal surgery.
• Gabapentin may be considered a valuable component of multimodal pain management strategies for scrotal surgery due to its efficacy and low risk of adverse events.
• Further research could explore optimal dosing and long-term effects, although current data suggest it does not impact opioid use or satisfaction.